Scinai Immunotherapeutics Files 6-K Amendment

TL;DR

SCIN filed a 6-K amendment, confirming 20-F annual reports and former name BiondVax.

AI Summary

Scinai Immunotherapeutics Ltd. filed an amendment (Amendment No. 1) to its Report on Form 6-K on September 9, 2024. This filing is an update for the month of September 2024 and indicates the company files annual reports under Form 20-F. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name on June 24, 2014.

Why It Matters

This filing serves as an update for investors regarding Scinai Immunotherapeutics' reporting status and historical company information.

Risk Assessment

Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically impact risk.

Key Players & Entities

• Scinai Immunotherapeutics Ltd. (company) — Registrant
• BiondVax Pharmaceuticals Ltd. (company) — Former company name
• September 9, 2024 (date) — Filing date of amendment
• 20240630 (date) — Conformed period of report

FAQ

From the Filing

0001213900-24-076707.txt : 20240909 0001213900-24-076707.hdr.sgml : 20240909 20240909072358 ACCESSION NUMBER: 0001213900-24-076707 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 50 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240909 DATE AS OF CHANGE: 20240909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Scinai Immunotherapeutics Ltd. CENTRAL INDEX KEY: 0001611747 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37353 FILM NUMBER: 241285855 BUSINESS ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 BUSINESS PHONE: 972-8-9302529 MAIL ADDRESS: STREET 1: JERUSALEM BIOPARK, 2ND FLOOR STREET 2: HADASSAH EIN KEREM CAMPUS CITY: JERUSALEM STATE: L3 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BiondVax Pharmaceuticals Ltd. DATE OF NAME CHANGE: 20140624 6-K 1 ea0212497-6k_scinai.htm REPORT OF FOREIGN PRIVATE ISSUER     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934   For the Month of September 2024   Commission File Number: 001-37353   SCINAI IMMUNOTHERAPEUTICS LTD. (Translation of registrant’s name into English)   Jerusalem BioPark, 2nd Floor Hadassah Ein Kerem Campus Jerusalem, Israel (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.   Form 20-F ☒       Form 40-F ☐           Explanatory Note     This Amendment No. 1 to the Report on Form 6-K, originally filed with the Securities and Exchange Commission on August 15, 2024 (“Original 6-K”), is being filed solely for the purposes of furnishing unaudited interim condensed consolidated financial statements as of June 30, 2024, which were inadvertently not included in the Original 6-K, and incorporating certain exhibits into registration statements of the registrant.    A copy of the press release is furnished herewith as Exhibit 99.1, and a copy of the unaudited interim condensed consolidated financial statements as of June 30, 2024 is furnished herein as Exhibit 99.2.   This Report on Form 6-K is hereby incorporated by reference into the registrant’s Registration Statements on Form S-8 (File No.  333-271293  and File No.  333-239344 ) and Form F-3 (File No.  333-274078  and File No.  333-276767 ), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   Exhibit Index   Exhibit No.   Description 99.1   Press release dated August 15, 2024. 99.2   Unaudited Interim Condensed Consolidated Financial Statements as of June 30, 2024 101.INS   Inline XBRL Instance Document 101.SCH   Inline XBRL Taxonomy Extension Schema Document. 101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).   1     SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     Scina